SOPHiA GENETICS S.A.
SOPH · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.09 | -0.24 | 0.19 | -0.15 |
| FCF Yield | -4.53% | -5.52% | -6.13% | -4.42% |
| EV / EBITDA | -9.49 | -13.18 | -12.63 | -13.55 |
| Quality | ||||
| ROIC | -12.97% | -13.75% | -13.91% | -10.40% |
| Gross Margin | 66.97% | 68.67% | 68.25% | 67.20% |
| Cash Conversion Ratio | 0.44 | 0.38 | 0.64 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.68% | 8.84% | 9.86% | 11.07% |
| Free Cash Flow Growth | 22.83% | 2.39% | -17.17% | 6.95% |
| Safety | ||||
| Net Debt / EBITDA | 1.66 | 2.76 | 4.10 | 4.88 |
| Interest Coverage | -33.20 | -24.33 | -9.12 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.97 | 1.10 | 0.96 | 0.80 |
| Cash Conversion Cycle | 24.15 | 61.31 | 107.01 | 65.95 |